Connect with us

Business

Morison commences commercial production at State-of-the-Art new pharmaceutical manufacturing facility

Published

on

Morison Ltd., one of the pioneers of pharmaceutical manufacturing in Sri Lanka since 1959, announced the commencement of commercial production at its state-of the-art WHO GMP and EU GMP compliant production facility in Pitipana, Homagama. Unveiled in late 2020 as Sri Lanka’s first and largest general oral solid and liquid dosage pharmaceutical manufacturing facility, the factory marked the launch of commercial production by manufacturing and releasing its 1st commercial batches of Chlorphenamine Oral Solution and Paracetamol 500mg tablets to the market on the 26th of May.

Marking a new era in the pharmaceutical manufacturing industry in Sri Lanka, with a commitment to increase access of high quality yet affordable medicines, Morison’s investment of LKR 4 billion in its new state-of-the-art pharmaceutical research and manufacturing facility, is the highest investment to date in the local pharma manufacturing industry. The facility, the first general oral solid and liquid dosage manufacturing plant in Sri Lanka, built as per European Union-Good Manufacturing Practice (EU-GMP) specifications and Quality Management Systems, has a capacity to manufacture over 5 Bn tablets and 2 Mn litres of liquid during two shifts, which can cater up to 40% of the national demand.

“With the launch of commercial production at our new facility, Morison continues its 60-year long mission to offer the highest quality products at affordable prices to Sri Lankans. We are humbled at being able to fulfill the medicinal needs of our people with locally manufactured essential drugs at a time of crisis for the nation. Today, we release our first batches of medicine produced at the new facility, with the seal of approval of the National Medicines Regulatory Authority (NMRA), marking a new era for local pharmaceuticals manufacture. In this journey, we envision to build a high-quality pharmaceutical brand manufactured in Sri Lanka, and act on our purpose of “Making Premium Healthcare Affordable”. We aspire to drive this within a six-pillar framework of being Truly Sri Lankan, with Global Quality, at a Local Price, introducing Novel Therapies, maintaining Ethical Standards and safeguarding Credibility. In this endeavour we undertake the responsibility of building a set of high caliber professionals to take Sri Lanka’s pharma manufacturing industry forward.” stated Dinesh Athapaththu, Managing Director of Morison Limited.

Living up to its purpose, Morison recently launched the 1st locally manufactured SGLT-2, a new generation Diabetes molecule – Empagliflozin at a cost that is approximately 50% lesser than the prevailing market prices. According to the company, it is also working on a new product pipeline which will include some of the latest therapies predominantly in diabetic, cardiovascular and vitamin segments.

Further, leveraging the long-lasting relationships of the Hemas Group, Morison has signed up for contract manufacturing arrangements with a few leading regional pharmaceutical companies, which will be operationalized during the year.

Morison is hopeful that it can make a step change in the pharma manufacturing industry in Sri Lanka while helping to save much needed forex at this juncture and eventually build an export business.



Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Why Sri Lanka’s new environmental penalties could redraw the Economics of Growth

Published

on

Kapila Mahesh Rajapaksha: Environmental protection, part of national productivity

For decades, environmental crime in Sri Lanka has been cheap.

Polluters paid fines that barely registered on balance sheets, violations dragged through courts and the real costs — poisoned waterways, degraded land, public health damage — were quietly transferred to the public. That arithmetic, long tolerated, is now being challenged by a proposed overhaul of the country’s environmental penalty regime.

At the centre of this shift is the Central Environmental Authority (CEA), which is seeking to modernise the National Environmental Act, raising penalties, tightening enforcement and reframing environmental compliance as an economic — not merely regulatory — issue.

“Environmental protection can no longer be treated as a peripheral concern. It is directly linked to national productivity, public health expenditure and investor confidence, CEA Director General Kapila Mahesh Rajapaksha told The Island Financial Review. “The revised penalty framework is intended to ensure that the cost of non-compliance is no longer cheaper than compliance itself.”

Under the existing law, many pollution-related offences attract fines so modest that they have functioned less as deterrents than as operating expenses. In economic terms, they created a perverse incentive: pollute first, litigate later, pay little — if at all.

The proposed amendments aim to reverse this logic. Draft provisions increase fines for air, water and noise pollution to levels running into hundreds of thousands — and potentially up to Rs. 1 million — per offence, with additional daily penalties for continuing violations. Some offences are also set to become cognisable, enabling faster enforcement action.

“This is about correcting a market failure, Rajapaksha said. “When environmental damage is not properly priced, the economy absorbs hidden losses — through healthcare costs, disaster mitigation, water treatment and loss of livelihoods.”

Those losses are not theoretical. Pollution-linked illnesses increase public healthcare spending. Industrial contamination damages agricultural output. Environmental degradation weakens tourism and raises disaster-response costs — all while eroding Sri Lanka’s natural capital.

Economists increasingly argue that weak environmental enforcement has acted as an implicit subsidy to polluting industries, distorting competition and discouraging investment in cleaner technologies.

The new penalty regime, by contrast, signals a shift towards cost internalisation — forcing businesses to account for environmental risk as part of their operating model.

The reforms arrive at a time when global capital is becoming more selective. Environmental, Social and Governance (ESG) benchmarks are now embedded in lending, insurance and trade access. Countries perceived as weak on enforcement face higher financing costs and shrinking market access.

“A transparent and credible environmental regulatory system actually reduces investment risk, Rajapaksha noted. “Serious investors want predictability — not regulatory arbitrage that collapses under public pressure or litigation.”

For Sri Lanka, the implications are significant. Stronger enforcement could help align the country with international supply-chain standards, particularly in manufacturing, agribusiness and tourism — sectors where environmental compliance increasingly determines competitiveness.

Business groups are expected to raise concerns about compliance costs, particularly for small and medium-scale enterprises. The CEA insists the objective is not to shut down industry but to shift behaviour.

“This is not an anti-growth agenda, Rajapaksha said. “It is about ensuring growth does not cannibalise the very resources it depends on.”

In the longer term, stricter penalties may stimulate demand for environmental services — monitoring, waste management, clean technology, compliance auditing — creating new economic activity and skilled employment.

Yet legislation alone will not suffice. Sri Lanka’s environmental laws have historically suffered from weak enforcement, delayed prosecutions and institutional bottlenecks. Without consistent application, higher penalties risk remaining symbolic.

The CEA says reforms will be accompanied by improved monitoring, digitalised approval systems and closer coordination with enforcement agencies.

By Ifham Nizam

Continue Reading

Business

Milinda Moragoda meets with Gautam Adani

Published

on

Milinda Moragoda, Founder of the Pathfinder Foundation, who was in New Delhi to participate at the 4th India-Japan Forum, met with Gautam Adani, Chairman of Adani Group.

Adani Group recently announced that they will invest US$75 billion in the energy transition over the next 5 years. They will also be investing $5 billion in Google’s AI data center in India.Milinda Moragoda,

Milinda Moragoda, was invited by India’s Ministry of External Affairs and the Ananta Centre to participate in the 4th India–Japan Forum, held recently in New Delhi. In his presentation, he proposed that India consider taking the lead in a post-disaster reconstruction and recovery initiative for Sri Lanka, with Japan serving as a strategic partner in this effort. The forum itself covered a broad range of issues related to India–Japan cooperation, including economic security, semiconductors, trade, nuclear power, digitalization, strategic minerals, and investment.

The India-Japan Forum provides a platform for Indian and Japanese leaders to shape the future of bilateral and strategic partnerships through deliberation and collaboration. The forum is convened by the Ministry of External Affairs, Government of India, and the Anantha Centre.

Continue Reading

Business

HNB Assurance welcomes 2026 with strong momentum towards 10 in 5

Published

on

Lasitha Wimalaratne – Executive Director / CEO, HNB Assurance.

HNB Assurance enters 2026 with renewed purpose and clear ambition as it moves into a defining phase of its 10 in 5 strategic journey. With the final leg toward achieving a 10% life insurance market share by 2026 now in focus, the company is gearing up for a year of transformation, innovation, and accelerated growth.

Closing 2025 on a strong note, HNB Assurance delivered outstanding results, continuously achieving growth above the industry average while strengthening its people, partnerships and brand. Industry awards, other achievements, and continued customer trust reflect the company’s strong performance and ongoing commitment to providing meaningful protection solutions for all Sri Lankans.

Commenting on the year ahead, Lasitha Wimalarathne, Executive Director / Chief Executive Officer of HNB Assurance, stated, “Guided by our 2026 theme, ‘Reimagine. Reinvent. Redefine.’, we are setting our sights beyond convention. Our aim is to reimagine what is possible for the life insurance industry, for our customers, and for the communities we serve, while laying a strong foundation for the next 25 years as a trusted life insurance partner in Sri Lanka. This year, we also celebrate 25 years of HNB Assurance, a milestone that is special in itself and a testament to the trust and support of our customers, partners and people. For us, success is not defined solely by financial performance. It is measured by the trust we earn, the promises we honor, the lives we protect, and the positive impact we create for all our stakeholders. Our ambition is clear, to be a top-tier life insurance company that sets benchmarks in customer experience, professionalism and people development.”

For HNB Assurance looking back at a year of progress and recognition, the collective efforts of the team have created a strong momentum for the year ahead.

“The progress we have made gives us strong confidence as we enter the final phase of our 10 in 5 journey. Being recognized as the Best Life Insurance Company at the Global Brand Awards 2025, receiving the National-level Silver Award for Local Market Reach and the Insurance Sector Gold Award at the National Business Excellence Awards, and being named Best Life Bancassurance Provider in Sri Lanka for the fifth consecutive year by the Global Banking and Finance Review, UK, reflect the consistency of our performance, the strength of our strategy, along with the passion, and commitment of our people.”

Continue Reading

Trending